No. While there was concern in the past that ERMS with anaplasia may demonstrate a worse prognosis, more recent analyses have shown that isn't the case. A recent publication of the Children's Oncology Group experience by Shenoy et al. nicely summarizes the data from 5 recent RMS trials involving bot...